Sign in
Taking peopleNo phase

tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder

Key facts

Who runs it
Centre Hospitalier Henri Laborit
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
25 people, planned
Started
17 Oct 2023
Expected to end
Jul 2027
Type of study
Interventional
Treatments tested
  • tDCS + symptoms provocation
Record updated
23 October 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • Patient suffering from OCD evolving for at least 2 years diagnosed according to DSM-V criteria
  • Patient with good insight, defined by a score less than or equal to 18 at the threshold of delusions on the BABS (Brown Assessment of Beliefs Scale) insight scale
  • Absence of a current depressive episode (MADRS score < 21) or suicidal risk (MADRS score item 10 < 3)
  • Absence of epileptic pathology
  • Chronic obsessive-compulsive disorder defined by a total YBOCS score > 20, or a subscale score > 15
  • Drug-resistant obsessive-compulsive disorder despite treatment with:; at least 2 antidepressants of the IRS type at an effective dose and for a sufficient duration; and/or Behavioral and Cognitive therapy for at least 1 year
  • Therapeutic stability (antidepressants) for more than 12 weeks without significant improvement. This treatment, at a fixed dose, will be maintained during the study
  • Patient aged between 18 and 70 included
  • Patient who has given his/her informed consent after having received written information on the planned procedure
  • Patient benefiting from social security or by benefiting through a third party

Who cannot take part

  • Patient with another DSM-V Axis 1 diagnosis (Schizophrenic Disorder, Bipolar Disorder, Substance Abuse or Substance Dependence); Generalized anxiety disorder, social phobia, nicotine addiction and history of major depressive episodes are not exclusion criteria. Axis I comorbidity will be explored using MINI 5.0.0.
  • History of head trauma
  • Woman of childbearing age without effective means of contraception (hormonal/mechanical: oral, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy)
  • Pregnant or nursing woman
  • Patient hospitalized under duress (SPDT, SPDRE)
  • Patient under guardianship or curatorship
  • Patient suffering from a current depressive episode
  • Patient at risk of suicide
  • Patient with skin lesions on the scalp
  • Patient with an intracerebral metal object
  • Patient with a pacemaker
  • Presence of epileptic pathology
  • Patient in an emergency situation or unable to give personal consent

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a single-center study about patients with severe resistant OCD.

Read full original descriptionShow less

Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right orbitofrontal cortex, and the cathode at the level of the supplementary motor area, associated with the provocation of symptoms before each session is effective in the reduction in obsessive-compulsive symptoms.

After the inclusion visit, the treatment period is provided from D1 to D12 (one session per day from Monday to Friday, for two consecutive weeks, i.e. a total of ten sessions). Each tDCS session lasts 30 minutes at an intensity of 2 mA and is preceded by symptom provocation using a standardized procedure performed by trained personnel.

The patients are then assessed on D42 and D102 (i.e. 1 month and 3 months after the end of the tDCS sessions).

The group in the trial

  • tDCS + symptoms provocationTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Direct Transcranial Stimulation With Direct Current Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive
Criteria questions
Built from NCT06017713, who can take part
Record updated
23 October 2026